1. Home
  2. MTEN vs SCYX Comparison

MTEN vs SCYX Comparison

Compare MTEN & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEN
  • SCYX
  • Stock Information
  • Founded
  • MTEN 2015
  • SCYX 1999
  • Country
  • MTEN China
  • SCYX United States
  • Employees
  • MTEN N/A
  • SCYX N/A
  • Industry
  • MTEN Building Products
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEN Industrials
  • SCYX Health Care
  • Exchange
  • MTEN Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • MTEN 50.1M
  • SCYX 40.9M
  • IPO Year
  • MTEN 2024
  • SCYX 2014
  • Fundamental
  • Price
  • MTEN $12.10
  • SCYX $0.94
  • Analyst Decision
  • MTEN
  • SCYX
  • Analyst Count
  • MTEN 0
  • SCYX 0
  • Target Price
  • MTEN N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • MTEN 124.4K
  • SCYX 83.0K
  • Earning Date
  • MTEN 04-30-2025
  • SCYX 05-20-2025
  • Dividend Yield
  • MTEN N/A
  • SCYX N/A
  • EPS Growth
  • MTEN N/A
  • SCYX N/A
  • EPS
  • MTEN N/A
  • SCYX N/A
  • Revenue
  • MTEN $10,120,257.00
  • SCYX $3,746,000.00
  • Revenue This Year
  • MTEN N/A
  • SCYX $460.12
  • Revenue Next Year
  • MTEN N/A
  • SCYX $253.87
  • P/E Ratio
  • MTEN N/A
  • SCYX N/A
  • Revenue Growth
  • MTEN 23.03
  • SCYX N/A
  • 52 Week Low
  • MTEN $1.81
  • SCYX $0.73
  • 52 Week High
  • MTEN $14.99
  • SCYX $3.07
  • Technical
  • Relative Strength Index (RSI)
  • MTEN N/A
  • SCYX 47.33
  • Support Level
  • MTEN N/A
  • SCYX $0.93
  • Resistance Level
  • MTEN N/A
  • SCYX $1.00
  • Average True Range (ATR)
  • MTEN 0.00
  • SCYX 0.07
  • MACD
  • MTEN 0.00
  • SCYX -0.00
  • Stochastic Oscillator
  • MTEN 0.00
  • SCYX 7.60

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: